RMS is characterized by clearly defined attacks of worsening neurologic function. These attacks — often called relapses, flare-ups or exacerbations — are followed by partial or ... Sep 12
Aptorum Group Limited (Nasdaq: APM) (“Aptorum Groupâ€), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces the ... Sep 12
Aptorum Group Limited (Nasdaq: APM) (“Aptorum Groupâ€), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces that ... Sep 12
CIVCO Radiotherapy, the leading global provider of high quality, innovative, patient-centric radiotherapy solutions, will present their Universal Couchtopâ„¢ proton system along with several new ... Sep 12
deCODE genetics in Iceland has entered into an agreement with a consortium of government, charity, researchers and world leading biopharmaceutical and healthcare companies to undertake ... Sep 12
Dr. Debraj Shome was conferred with the award for his noteworthy contribution as a Facial Plastic Surgeon by noted actor and producer Neha Dhupia Actor ... Sep 12
Huawei, a leading global ICT and network energy solutions provider, teamed up with Jordanian solar manufacturer and developer Philadelphia Solar to power the world's ... Sep 12
Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Clobetasol Propionate Foam, 0.... Sep 12
Jubilant Life Sciences Limited has announced that Dr. Syed Kazmi, PhD, MBA, will join its new innovative biopharmaceutical company in the U.S., Jubilant Therapeutics ... Sep 12
Based on its recent analysis of the North American telehealth services market, Frost & Sullivan recognizes Boston-based American Well® with the 2019 North America Company ... Sep 12
Results include progression-free survival and overall survival data from Phase Ib/II INSIGHT study Phase II INSIGHT 2 study now open for enrollment for ... Sep 12
This is a summary of research presented this morning at the International Association for the Study of Lung Cancer's World Conference on Lung Cancer. ... Sep 12
The rosacea treatment algorithm, developed by ROSCO in 2017, has been updated with several new recommendations including the use of combination therapy to benefit severe ... Sep 12
... Sep 12
-Advertisements-